TScan Therapeutics, Inc 10-K for FY2021
TScan Therapeutics, Inc. (TCRX)
10-K
2022-03-09
For: 2021-12-31
View Original
Added on
April 06, 2026
About this 10-K
TScan Therapeutics, Inc filed this 10-K on March 9, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $10.14M
- up 834.7% from $1.09M a year earlier
- Net loss
- $48.63M
- compared with a net loss of $26.13M a year earlier